ProfileGDS5822 / ILMN_1213920
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 90% 86% 85% 91% 86% 90% 87% 91% 89% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1477.990
GSM1276600PDAC Late Ablation Control 2307.386
GSM1276601PDAC Late Ablation Control 3315.285
GSM1276602PDAC Late Ablation 1517.291
GSM1276603PDAC Late Ablation 2313.486
GSM1276604PDAC Late Ablation 3517.790
GSM1303940PDAC Late Ablation_anti-CTLA4 1327.187
GSM1303941PDAC Late Ablation_anti-CTLA4 2695.191
GSM1303942PDAC Late Ablation_anti-CTLA4 3494.489